MDMA targets miR-124/MEKK3 via MALAT1 to promote Parkinson’s disease progression

BACKGROUND: Parkinson’s disease (PD) is a well-known neurodegenerative disease that is usually caused by the progressive loss of dopamine neurons and the formation of Lewy vesicles. 3,4-Methylenedioxymethamphetamine (MDMA) has been reported to cause damage to human substantia nigra neurons and an in...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Xin, Li, Shipeng, Li, Jinghui, Qi, Renli, Zhong, Lianmei, Yu, Hualin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635915/
https://www.ncbi.nlm.nih.gov/pubmed/37688681
http://dx.doi.org/10.1007/s11033-023-08775-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635915/
https://www.ncbi.nlm.nih.gov/pubmed/37688681
http://dx.doi.org/10.1007/s11033-023-08775-w

Ejemplares similares